Concomitant anti-tumor necrosis factor and anti-interleukin 17 therapy in severe, refractory hidradenitis suppurativa: A case series.
Bastian E, Bizuneh L, Amerson EH, Naik HB
JAAD InternationalIn the feed 6 Oct 2026, published online 28 Aug 2026, issue 2026 Dec, added to PubMed 6 Oct 2026
Topics: Hidradenitis suppurativa
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42835218 · DOI 10.1016/j.jdin.2026.08.004